General information, not medical advice or an insurance coverage decision. MedraxDME operates as an out of network supplier. Coverage, supplier enrollment requirements and patient responsibility depend on the plan and an individual review.
Start with the coverage route
Original Medicare can cover a continuous glucose monitor and related supplies under Part B when its requirements are met. This is not limited to people with type 1 diabetes. A person with type 2 diabetes may qualify through insulin treatment or through the policy's documented problematic hypoglycemia pathway. The treating practitioner must determine whether a CGM is appropriate and document the required information. See Medicare: Continuous glucose monitor coverage and CMS: Glucose Monitors coverage policy L33822.
It helps to separate three decisions. Your clinician determines what monitoring is medically appropriate. Your insurer applies its benefit and documentation rules. A supplier determines whether it can serve your plan and provide the prescribed system. A positive answer to one question does not settle the other two. Seeing a device in a catalog also does not establish that your particular claim will be paid.
This guide describes coverage questions to discuss with your care team. It does not diagnose diabetes, recommend a treatment change or confirm that MedraxDME is enrolled in your particular Medicare arrangement.
The initial criteria in plain language
The CMS glucose monitor policy requires diabetes, a prescription that reflects adequate training for the patient or caregiver, use consistent with the device's FDA indications, and a qualifying treatment or hypoglycemia history. It also requires a treating practitioner visit within the six months before ordering. The visit can be in person or through Medicare approved telehealth and must establish the applicable criteria. CMS: Glucose Monitors coverage policy L33822.
The insulin pathway does not say that everyone must use an insulin pump or take three injections each day. Do not use an old article with those restrictions to decide that a current request is impossible. Equally, do not start insulin to satisfy an insurance rule. Your clinician should choose your treatment for clinical reasons and then document the actual regimen.
Make a short appointment agenda: ask whether a CGM is appropriate, which system fits your needs, how training will be provided, and whether the visit notes contain the coverage information. You do not need to interpret billing language yourself before having this discussion.
When the person does not use insulin
For someone who does not use insulin, occasional symptoms or a single mildly low reading do not automatically meet the policy. CMS describes a specific problematic hypoglycemia pathway. It includes recurrent level 2 events below 54 mg/dL despite more than one attempt to adjust medication or the treatment plan, or a level 3 event below that threshold involving an altered mental or physical state that requires another person's help. The associated policy article explains the supporting documentation. CMS: Glucose Monitors coverage policy L33822 and CMS: Glucose Monitor policy article A52464.
Do not manufacture a history or change the way events are described simply to match a rule. Give your clinician an accurate account and any records already available. The clinician should decide what the information means and whether it satisfies the policy. If your current history does not qualify, ask what monitoring is appropriate now and what your own plan may cover.
A coverage discussion is different from care for a current low glucose episode. Follow your established treatment plan, and seek urgent medical help when needed. Waiting for an equipment approval is not a substitute for timely care.
The receiver requirement matters
A smartphone can be convenient, but Medicare's DME benefit has a durable equipment requirement. CMS explains that a CGM displaying results only on a smartphone, without a qualifying receiver or integration into a qualifying insulin pump, does not meet that requirement. A phone can be used alongside the durable receiver. Actual use of the qualifying equipment matters; merely possessing an unused receiver is not the same thing. CMS: Glucose Monitor policy article A52464.
Ask the supplier which receiver is included or already on your record, whether it matches the prescribed sensor, and what instructions apply if you also use a phone. If your clinician plans an insulin pump integration, verify the complete combination rather than assuming any pump can act as the covered display device.
Keep the exact product names in your personal equipment list. Similar names can identify different sensor generations, wear periods or compatible displays. A clear list helps a benefits representative and a clinician discuss the same system without accidentally reviewing a different item.
Continuing coverage needs continuing care
For ongoing CGM coverage, CMS requires a practitioner visit every six months to document adherence to the CGM regimen and diabetes treatment plan. A prescription from the first year is not the whole continuing coverage record. Schedule follow up with your care team and tell them if using the equipment has become difficult. CMS: Glucose Monitors coverage policy L33822.
Before a refill is due, check whether the supplier is waiting for updated records, your confirmation of need, or a plan decision. Ask for the exact missing item and who should provide it. This is more useful than asking several offices to resend every document without knowing what is absent. Keep your own note of the next action, the responsible office and the expected response date.
Do not assume that an authorization lasts indefinitely or that a change in plan leaves the same supplier arrangement intact. A new insurance year, a new device, a move or a change in supplier can make it sensible to repeat the benefits check before the next shipment is arranged.
Questions about the supplier and your responsibility
Medicare advises patients to confirm that the prescribing clinician and DME supplier are enrolled in Medicare, and to ask whether the supplier accepts assignment. Medicare Advantage plans also have their own access and network arrangements. The name of an insurance company alone is not enough to identify the benefit. Medicare: Continuous glucose monitor coverage.
Ask the plan to confirm the specific supplier, exact prescribed model, required authorization, documentation and any amount for which you may be responsible. Request the answer or reference number in writing where possible. A website statement about nationwide service is not a promise of participation in every plan. MedraxDME describes its service as out of network and reviews requests individually.
If the plan directs you to a different eligible supplier, follow that confirmed route rather than assuming a website callback overrides the plan's rules. A useful benefits discussion should clarify the next step even when the answer is that the requested supplier cannot fulfill the insurance arrangement.
A practical preparation checklist
- Identify whether your coverage is Original Medicare, Medicare Advantage or another arrangement.
- Ask your clinician which exact CGM model is appropriate and whether the required visit documentation is current.
- Confirm the correct medical equipment or pharmacy route with the plan.
- Check supplier enrollment, network status and any assignment arrangements before supply.
- Ask what receiver, sensor and training arrangements are needed.
- Confirm any prior authorization and the status of supporting records.
- Discuss your responsibility and next refill process before accepting equipment.
Keep this checklist for your phone call. Personal identifiers, prescription documents and medical history belong in a secure channel arranged with the appropriate organization. They should not be pasted into a general website inquiry, social media message or public comment.
MedraxDME's callback form collects basic contact details so the team can explain next steps. It is not a Medicare enrollment form or an automated eligibility determination. You can also explore the diabetes equipment catalog before discussing the prescribed model with the team.
Questions and answers
Can someone with type 2 diabetes using basal insulin qualify?
Potentially. The current CMS criterion is insulin treatment, not a universal requirement for a particular number of daily injections. All other coverage and documentation requirements still apply.
Does a prescription guarantee Medicare payment?
No. Medical necessity, required records, equipment rules, supplier eligibility and the applicable plan arrangement must also be satisfied.
Can I request a callback without uploading my Medicare card?
Yes. MedraxDME uses a callback form. Do not submit a Medicare number, clinical records or insurance card through that form.
Sources and updates
- CMS: Glucose Monitors coverage policy L33822
- CMS: Glucose Monitor policy article A52464
- Medicare: Continuous glucose monitor coverage
- CMS: Standard Documentation Requirements A55426
Read our editorial and correction policy. For current plan rules, check the applicable official policy and contact your plan. Tell us about a correction.